Join Our Community!
Share
Cancer > Prostate Cancer Forum > Prostate Cancer Treatment And Fda Corruption Story
Millions of Americans are diagnosed with cancer. But what exactly is cancer and how does it affect the body?...
What puts you at risk for developing cancer? Learn how you can avoid or reduce exposure to risk factors for cancer here....
Cancer can occur anywhere in the body. But what are the signs and symptoms of cancer? Learn about general symptoms of cancer here....
Avatar
Q: Prostate Cancer Treatment And Fda Corruption Story
asked by: proven on November 11th, 2007
New User
"On October 28, 2004, the Dendreon Corporation from Seattle, Washington announced the results that showed an immunotherapy had extended the lives of men with late stage prostate cancer.

The standard of care for late stage prostate cancer is chemotherapy. While chemotherapy has helped some men, it is so toxic and has such severe side effects, that most men with late stage prostate cancer refuse to take it. Chemotherapy kills off healthy cells and cancerous cells indiscriminately. Provenge, an immunotherapy, rebuilds the immune system retraining the healthy cells to attack and destroy the invading cancer cells like they did when you were younger.

On June 29, 2006, Dendreon announced that it had published a pivotal Phase III study highlighting survival benefit and safety profiles of its prostate cancer treatment called Provenge.

On November 24, 2006, Dendreon completed submission of its Biologics License Application to the FDA.

On March 29, 2007, the FDA assembled an Advisory Committee to advise them on whether to approve Provenge. The panel voted Provenge was safe by an overwhelming vote of 17 to 0. They voted Provenge showed substantial evidence that it works by a vote of 13 to 4.

On April 13, 2007, a letter was “leaked” onto the internet via a non-peer medical publication called The Cancer Letter from one of the doctors who voted against Provenge’s efficacy. This prominent New York City doctor, Dr. Howard Scher, who had serious conflicts of interests, vehemently protested the approval of Provenge.

On April 26, 2007, another letter was “leaked” via The Cancer Letter from another conflicted doctor, Dr. Maha Hussain, who also voted against Provenge’s efficacy.

A third letter was “leaked” via The Cancer Letter on May 4, 2007, this time from a non-panel member, denouncing the approval of Provenge.

Finally, on May 8, 2007, the FDA delayed the approval of Provenge by asking for more data. It left 30,000 men without hope."

I'm just trying to spread the word here.
Did you find this post useful?
|
Replies(1)
User Profile
MandMs
replied on November 13th, 2007
Extremely eHealthy
Thanks for shearing this information with us.
Hoping for an approval of Provenge and help for all prostate cancer suffers.
Did you find this post useful?
|
Quick Reply
Search